229 related articles for article (PubMed ID: 26180022)
1. Biased Agonism of the Angiotensin II Type I Receptor.
Ikeda Y; Kumagai H; Motozawa Y; Suzuki J; Komuro I
Int Heart J; 2015; 56(5):485-8. PubMed ID: 26180022
[TBL] [Abstract][Full Text] [Related]
2. Allosteric modulation of β-arrestin-biased angiotensin II type 1 receptor signaling by membrane stretch.
Tang W; Strachan RT; Lefkowitz RJ; Rockman HA
J Biol Chem; 2014 Oct; 289(41):28271-83. PubMed ID: 25170081
[TBL] [Abstract][Full Text] [Related]
3. Cardiorenal actions of TRV120027, a novel ß-arrestin-biased ligand at the angiotensin II type I receptor, in healthy and heart failure canines: a novel therapeutic strategy for acute heart failure.
Boerrigter G; Lark MW; Whalen EJ; Soergel DG; Violin JD; Burnett JC
Circ Heart Fail; 2011 Nov; 4(6):770-8. PubMed ID: 21835984
[TBL] [Abstract][Full Text] [Related]
4. β-Arrestin-Biased Agonist Targeting the Brain AT
Zanaty M; Seara FAC; Nakagawa P; Deng G; Mathieu NM; Balapattabi K; Karnik SS; Grobe JL; Sigmund CD
Hypertension; 2021 Feb; 77(2):420-431. PubMed ID: 33249862
[TBL] [Abstract][Full Text] [Related]
5. Beta-arrestins in the context of cardiovascular diseases: Focusing on angiotensin II type 1 receptor (AT1R).
Lino CA; Barreto-Chaves ML
Cell Signal; 2022 Apr; 92():110253. PubMed ID: 35077849
[TBL] [Abstract][Full Text] [Related]
6. TRV120027, a novel β-arrestin biased ligand at the angiotensin II type I receptor, unloads the heart and maintains renal function when added to furosemide in experimental heart failure.
Boerrigter G; Soergel DG; Violin JD; Lark MW; Burnett JC
Circ Heart Fail; 2012 Sep; 5(5):627-34. PubMed ID: 22891045
[TBL] [Abstract][Full Text] [Related]
7. β-Arrestin-biased AT1R stimulation promotes extracellular matrix synthesis in renal fibrosis.
Wang Y; Huang J; Liu X; Niu Y; Zhao L; Yu Y; Zhou L; Lu L; Yu C
Am J Physiol Renal Physiol; 2017 Jul; 313(1):F1-F8. PubMed ID: 28274926
[TBL] [Abstract][Full Text] [Related]
8. Adrenal angiotensin II type 1 receptor biased signaling: The case for "biased" inverse agonism for effective aldosterone suppression.
Ferraino KE; Cora N; Pollard CM; Sizova A; Maning J; Lymperopoulos A
Cell Signal; 2021 Jun; 82():109967. PubMed ID: 33640432
[TBL] [Abstract][Full Text] [Related]
9. Biased agonism of the angiotensin II type 1 receptor.
Godin CM; Ferguson SS
Mini Rev Med Chem; 2012 Aug; 12(9):812-6. PubMed ID: 22681254
[TBL] [Abstract][Full Text] [Related]
10. Selectively engaging β-arrestins at the angiotensin II type 1 receptor reduces blood pressure and increases cardiac performance.
Violin JD; DeWire SM; Yamashita D; Rominger DH; Nguyen L; Schiller K; Whalen EJ; Gowen M; Lark MW
J Pharmacol Exp Ther; 2010 Dec; 335(3):572-9. PubMed ID: 20801892
[TBL] [Abstract][Full Text] [Related]
11. β-Arrestin-biased AT1R stimulation promotes cell survival during acute cardiac injury.
Kim KS; Abraham D; Williams B; Violin JD; Mao L; Rockman HA
Am J Physiol Heart Circ Physiol; 2012 Oct; 303(8):H1001-10. PubMed ID: 22886417
[TBL] [Abstract][Full Text] [Related]
12. Differential β-arrestin-dependent conformational signaling and cellular responses revealed by angiotensin analogs.
Zimmerman B; Beautrait A; Aguila B; Charles R; Escher E; Claing A; Bouvier M; Laporte SA
Sci Signal; 2012 Apr; 5(221):ra33. PubMed ID: 22534132
[TBL] [Abstract][Full Text] [Related]
13. Mechanoactivation of the angiotensin II type 1 receptor induces β-arrestin-biased signaling through Gα
Wang J; Hanada K; Gareri C; Rockman HA
J Cell Biochem; 2018 Apr; 119(4):3586-3597. PubMed ID: 29231251
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin II type 1 receptor variants alter endosomal receptor-β-arrestin complex stability and MAPK activation.
Cao Y; Kumar S; Namkung Y; Gagnon L; Cho A; Laporte SA
J Biol Chem; 2020 Sep; 295(38):13169-13180. PubMed ID: 32703898
[TBL] [Abstract][Full Text] [Related]
15. Beta-arrestin2-mediated inotropic effects of the angiotensin II type 1A receptor in isolated cardiac myocytes.
Rajagopal K; Whalen EJ; Violin JD; Stiber JA; Rosenberg PB; Premont RT; Coffman TM; Rockman HA; Lefkowitz RJ
Proc Natl Acad Sci U S A; 2006 Oct; 103(44):16284-9. PubMed ID: 17060617
[TBL] [Abstract][Full Text] [Related]
16. Proximal tubule NHE3 activity is inhibited by beta-arrestin-biased angiotensin II type 1 receptor signaling.
Carneiro de Morais CP; Polidoro JZ; Ralph DL; Pessoa TD; Oliveira-Souza M; Barauna VG; Rebouças NA; Malnic G; McDonough AA; Girardi AC
Am J Physiol Cell Physiol; 2015 Oct; 309(8):C541-50. PubMed ID: 26246427
[TBL] [Abstract][Full Text] [Related]
17. Distinct Mechanisms of β-Arrestin-Biased Agonist and Blocker of AT1R in Preventing Aortic Aneurysm and Associated Mortality.
Jara ZP; Harford TJ; Singh KD; Desnoyer R; Kumar A; Srinivasan D; Karnik SS
Hypertension; 2023 Feb; 80(2):385-402. PubMed ID: 36440576
[TBL] [Abstract][Full Text] [Related]
18. c-Src regulates clathrin adapter protein 2 interaction with beta-arrestin and the angiotensin II type 1 receptor during clathrin- mediated internalization.
Fessart D; Simaan M; Laporte SA
Mol Endocrinol; 2005 Feb; 19(2):491-503. PubMed ID: 15498833
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin II cyclic analogs as tools to investigate AT
St-Pierre D; Cabana J; Holleran BJ; Besserer-Offroy É; Escher E; Guillemette G; Lavigne P; Leduc R
Biochem Pharmacol; 2018 Aug; 154():104-117. PubMed ID: 29684376
[TBL] [Abstract][Full Text] [Related]
20. Ang-(1-7) is an endogenous β-arrestin-biased agonist of the AT
Teixeira LB; Parreiras-E-Silva LT; Bruder-Nascimento T; Duarte DA; Simões SC; Costa RM; Rodríguez DY; Ferreira PAB; Silva CAA; Abrao EP; Oliveira EB; Bouvier M; Tostes RC; Costa-Neto CM
Sci Rep; 2017 Sep; 7(1):11903. PubMed ID: 28928410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
